Rein Therapeutics Inc. (RNTX)

Rein Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 28, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	39	50	15	11	51	42
Market Cap Growth	234.56%	234.56%	38.39%	-78.89%	20.50%	165.52%
Enterprise Value	26	77	3	-15	-1	33
Last Close Price	1.76	2.30	3.05	2.37	11.26	20.80
PB Ratio	4.06	0.92	0.15	0.58	1.16	3.48
P/TBV Ratio	-	-	-	0.58	1.16	3.48
Debt / Equity Ratio	-	-	0	0.00	0.00	0.03
Quick Ratio	2.24	2.24	3.95	6.28	10.19	3.49
Current Ratio	2.38	2.38	4.17	6.46	10.69	4.12
Return on Equity (ROE)	-82.37%	-82.37%	-26.91%	-87.41%	-93.33%	-150.00%
Return on Assets (ROA)	-20.89%	-20.89%	-14.99%	-49.03%	-51.30%	-59.84%
Return on Capital (ROIC)	-23.01%	-23.01%	-16.40%	-55.10%	-58.74%	-76.18%
Earnings Yield	-162.46%	-126.19%	-105.62%	-253.93%	-51.32%	-50.00%
FCF Yield	-57.59%	-44.73%	-132.99%	-231.03%	-46.90%	-48.41%
Buyback Yield / Dilution	-290.09%	-290.09%	-1.31%	-2.23%	-154.70%	-42.11%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q